Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05762380 · ClinicalTrials.gov registry record · NA

Effect of Iron Supplements on the Growth of Enteric Pathogens

A NA study of Iron Deficiency Anemia and Iron-deficiency, sponsored by Iowa State University.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT05762380 is a NA study of Iron Deficiency Anemia and Iron-deficiency that has completed, run by Iowa State University. The registered enrollment target is 15 participants, below the 193-participant average among 24 other Iron Deficiency Anemia trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05762380, a NA study of Iron Deficiency Anemia and Iron-deficiency, has completed, sponsored by Iowa State University.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

Iron supplementation is a common approach to address iron deficiency with recommendations for women of childbearing age, particularly those at risk of iron deficiency. Because of its considerably higher absorption, ferrous sulphate is the common iron compound used in iron supplements. However, concerns about iron supplements arise from the knowledge that a large portion of the supplement consumed is not absorbed. This unabsorbed iron travels to the colon and, in preclinical studies, has been shown to promote the growth of enteric pathogens at the expense of beneficial commensal bacteria and increase infection risk, including the clinical incidence of diarrhea. The objective of this study is to compare the effects of iron as ferrous sulfate (FeSO4) or FeSO4-enriched Aspergillus oryzae (Ao iron) on the growth and virulence of common enteric pathogens using an in vitro fecal fermentation model. Stool samples will be collected from women of reproductive age following ingestion of an iron supplement as either FeSO4 or Ao iron. Stool samples will be spiked with common enteric pathogens, and outcome measures will be determined following in vitro fecal fermentation.

Interventions

  • DIETARY_SUPPLEMENT Ferrous sulfate
  • DIETARY_SUPPLEMENT Ferrous sulfate-enriched Aspergillus oryzae (Ao iron)

Study Locations (1)

Iowa

  • Iowa State University - Ames

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2022-06-14
Est. Completion 2022-08-02
Phase NA

Sponsor

Iowa State University

23 total trials

What the Registry Record Tells You About NCT05762380

The ClinicalTrials.gov registry entry for NCT05762380 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 24 other Iron Deficiency Anemia trials with a reported enrollment target (92% lower). The listed sponsor is Iowa State University, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Iron Deficiency Anemia appearing as the primary indexed condition, and to 2 interventions - of which Ferrous sulfate is the first listed.

NCT05762380 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT05762380 about?

NCT05762380 is a clinical study titled "Effect of Iron Supplements on the Growth of Enteric Pathogens". Iron supplementation is a common approach to address iron deficiency with recommendations for women of childbearing age, particularly those at risk of iron deficiency. Because of its considerably higher absorption, ferrous sulphate is the common iron compound used in iron supplements. However, conce...

What is the current status of trial NCT05762380?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-06-14. Estimated completion is 2022-08-02.

What conditions does trial NCT05762380 study?

This clinical trial studies the following conditions: Iron Deficiency Anemia, Iron-deficiency, Iron Deficiency Anaemia Due to Dietary Causes, Iron Deficiency Anemia Treatment.

What interventions are being tested in trial NCT05762380?

The interventions under investigation include: Ferrous sulfate (DIETARY_SUPPLEMENT), Ferrous sulfate-enriched Aspergillus oryzae (Ao iron) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05762380?

This trial is sponsored by Iowa State University, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05762380 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Iron Deficiency Anemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.